TerminatedNCT00148616
Official study titleMemantine add-on to Risperidon for Treatment of Negative Symptoms and Cognitive Dysfunction in Patients With Chronic Schizophrenia: Results of a Proof of Concept Study
This study ended early.
In BerlinSchizophreniaMedication studyAges 18–40
- Countries
- Germany
- Sponsor
- M. Schaefer, MD
CompletedNCT00466310
About this title
Metabolic Signatures and Biomarkers in Schizophrenia
Read the official source — NCT00466310Official study titleMetabolic Signatures and Biomarkers in First Episode and Recurrent Patients With Schizophrenia in Comparison to Healthy Controls
This study has finished and is no longer accepting participants.
In ButnerSchizophreniaMedication studyAges 18–60
- Countries
- United States
- Sponsor
- Duke University
TerminatedNCT01177709
Official study titleEvaluation of the Efficacy of Metformin for Weight Loss and Metabolic Effects In Overweight Psychiatric Patients Treated With Antipsychotic Medication
This study ended early.
In New YorkSchizophreniaMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Nathan Kline Institute for Psychiatric Research
CompletedNCT02420015
This study has finished and is no longer accepting participants.
In DurhamSchizophreniaMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Duke University
CompletedNCT00711464
Official study titleA Dose-response Study of Modafinil Effects on Cognition in Schizophrenia Patients.
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesSchizophreniaMedication studyAges 18–54
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedNCT04141540
Official study titleTranslational 22q11.2:"Molecular Variants Associated With Schizophrenia: Differential Analysis of Monozygotic Twins With Variable Phenotypic 22q11.2 Microdeletional Syndrom"
This study has finished and is no longer accepting participants.
In LyonSchizophreniaInterventional studyAges 18–45
- Countries
- France
- Sponsor
- Hôpital le Vinatier
CompletedNCT02194933
Official study titleProtocol 331-13-009: An Exploratory, Multicenter, Randomized, Double-Blind, fMRI Study of Fixed-dose Brexpiprazole (OPC-34712) (2 and 4 mg/Day Tablets) in Adults With Schizophrenia With Impulsivity
This study has finished and is no longer accepting participants.
In OrangeSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT02734927
This study has finished and is no longer accepting participants.
In BronSchizophreniaInterventional studyAges 18–45
- Countries
- France
- Sponsor
- Hôpital le Vinatier
CompletedNCT04941352
Official study titleThe Effect of Interpersonal Relations Theory-Based Motivational Interviews on Functional Recovery and Insight Levels of Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In DenizliSchizophreniaBehavioural studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Pamukkale University
CompletedNCT02413164
Official study titleEffectiveness of a Multimodal Physical Therapy Program on Clinical Symptomatology and Physical Fitness in Persons With Schizophrenia
This study has finished and is no longer accepting participants.
In MálagaSchizophreniaInterventional studyAges 18–60
- Countries
- Spain
- Sponsor
- University of Malaga
CompletedNCT02332798
What is this study about?This study evaluated the safety of PF-04958242 for people with schizophrenia.
This study has finished and is no longer accepting participants.
In Long BeachSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Biogen
CompletedNCT03190161
Official study titleMusic to Reduce Use of Smoking in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkSchizophrenia, AddictionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- NYU Langone Health